Concord Biotech's Limbasi unit clears Brazilian health regulatory inspection

Concord Biotech announced the successful completion of an ANVISA inspection conducted by the Brazilian Health Regulatory Agency at the company's API manufacturing facility in Limbasi. The inspection took place from 08 June to 12 June 2026, and was concluded successfully.